Key facts
- Notable investors include Intellectual Property Acceleration Program for Startups, BD Fund, Brave Gate, Premo Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Delispect
- ·The full record, as it builds
Funding rounds
No funding rounds for Delispect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Delispect
Operator of a medical technology startup intended to use digital technology to tackle the medical challenges of an aging society. The company is developing an AI medical device, delispect, to predict and prevent delirium, a consciousness disorder that is common in the elderly, and they aim to solve the medical issues of all people involved with delirium, enabling individuals to get medical care.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Website
- delispect.com/
- Ownership
- Privately Held (backing)
Delispect doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Delispect shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Delispect in its N-PORT filings yet. We sweep new filings monthly.